Intracranial haemorrhage in thrombocytopenic haematology patients

Not Applicable

Completed

• Conditions: Intracranial haemorrhage in patients with haematological malignancies; Haematological Disorders; Intracranial haemorrhage

• Registration Number: ISRCTN05026912
• Lead Sponsor: ational Health Service Blood and Transplant (NHSBT) (UK)

Brief Summary

2014 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/24508852

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-06-17
• Study Completion: 2015-05-01
• Last Update Posted: 3 August 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 156

Inclusion Criteria

1. All thrombocytopenic adult haematology patients in the UK undergoing intensive chemotherapy (defined as chemotherapy expected to cause a significant thrombocytopenia < 50 x 10E9/L for > 5 days) or a stem cell transplant who had an intracranial haemorrhage within the study period
2. Aged 16 years or older
3. Only patients being treated with curative intent
4. All severities of intracranial haemorrhage
5. All types of intracranial haemorrhage

Exclusion Criteria

Does not meet the inclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified